The Wilcoxon test confirmed that the expression trends of feature genes in control and disease samples were consistent across both datasets, with SLC7A5 showing significant upregulation in HNSCC samples (p< 0.01) (Figures 3E–H). This evidence concerns the gene SLC7A5 and head and neck squamous cell carcinoma.